MEDICALLY REVIEWED

Omlonti (Omidenepag Isopropyl) for the Reduction of Elevated Intraocular Pressure

Omlonti
On 22 Sep 2022, the US FDA approved Omlonti® 0.002% eye drops for the reduction of elevated intraocular pressure. Read more

Log In as a healthcare professional to read the full article.

Share via

Also worth reading

People also read: